Corrigendum cum addendum to the Notice of Extra-Ordinary General Meeting of the Company held on 3rd June, 2025 at 03:00 P.M. through VC/OAVM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies has issued a corrigendum to the notice of its Extra-Ordinary General Meeting (EGM) scheduled for 3rd June, 2025 at 3:00 PM via video conferencing. The changes include revisions to the explanatory statements for Resolutions No. 2 and 3, which relate to the preferential issue and allotment of equity shares (other than cash) at a price of Rs. 10.00 per share (floor price of Rs. 9.99 per share based on the registered valuer's report). Additionally, a new Resolution No. 5 has been added to regularise the appointment of Ms. Pushpa Joshi (DIN: 06838093) as a Non-Executive and Independent Director for a 5-year term from 31st March, 2025 to 30th March, 2030. These revisions were made pursuant to queries raised by BSE Limited on 16th May, 2025.
The preferential share allotment at Rs. 10 per share will lead to equity dilution for existing shareholders once approved. The regularisation of the independent director appointment is a routine compliance requirement and signals strengthening of board governance.